Table 2.
Outcome Variable Findings at Follow-up
Characteristic | TAU (n = 95) | RP (n = 88) | MBRP (n = 103) |
---|---|---|---|
Sample size % completed, No. (%) | |||
3 mo | 82 (86.3) | 80 (90.9) | 95 (92.2) |
6 mo | 77 (81.1) | 75 (85.2) | 89 (86.4) |
12 mo | 76 (80.0) | 72 (81.8) | 83 (80.6) |
Drug use days, TLFB, mean (SD) | |||
3 mo | 5.23 (15.43) | 2.09 (10.65) | 3.92 (16.24) |
6 mo | 5.81 (19.11) | 1.71 (10.77) | 2.73 (12.00) |
12 mo | 4.63 (16.03) | 6.09 (19.05) | 3.06 (15.08) |
Any drug use, TLFB, No. (%) | |||
3 mo | 20 (21.0) | 11 (12.5) | 14 (13.6) |
6 mo | 20 (21.0) | 7 (8.0) | 10 (9.7) |
12 mo | 13 (13.7) | 15 (17.0) | 9 (8.7) |
Heavy drinking days, TLFB, mean (SD) | |||
3 mo | 2.64 (10.64) | 2.13 (7.75) | 1.99 (8.06) |
6 mo | 2.61 (9.93) | 1.13 (5.96) | 1.63 (8.53) |
12 mo | 4.65 (14.93) | 3.89 (12.17) | 1.44 (7.66) |
Any heavy drinking, TLFB, No. (%) | |||
3 mo | 19 (20.0) | 18 (20.5) | 12 (11.7) |
6 mo | 15 (15.8) | 8 (9.1) | 8 (7.8) |
12 mo | 19 (20.0) | 17 (19.3) | 8 (7.8) |
Abbreviations: MBRP, mindfulness-based relapse prevention; RP, relapse prevention; TAU, treatment as usual; TLFB, Timeline Follow-back.